Biosimilar Indications and Routes of Administration

Carl D. Regillo, MD, and Jennifer I. Lim, MD, caution against the ophthalmic use of biosimilar products approved for systemic use. They also review how indications for biosimilars are granted upon approval.

Clinical Findings for Biosimilars in the Treatment of Retinal Disorders

Carl D. Regillo, MD, and Jennifer I. Lim, MD, review clinical trial data for biosimilar products, with interpretation of safety data when comparing to the biologic reference products.

GA therapy demonstrates continuous, sustained effects of pegcetacoplan over time

Physician offers "real talk" on pros and cons that offers surgeons and patients decision-making insights.